QRxPharma Limited: John Holaday, CEO - ASX Spotlight Series May 2010
Mon, 24 May 2010 2:00pm
QRXPHARMA LTD (QRX)
Video loading... this content requires Flash. If your device supports Flash please click here to install.
Edward Rudnic,
QRxPharma Limited presents at ASX Small to Mid Caps conference in New York
Mon, 2 Apr 2012 4:00pm
Edward Rudnic, Chief Operatign Officer
Chris Campbell
QRxPharma Limited - ASX Small to Mid Caps Conference in Singapore and Hong Kong
Fri, 4 Nov 2011 10:25am
Chris Campbell, Chief Financial Officer
Janette Dixon
QRX to present at the ASX small to mid caps conference in Hong Kong and Singapore
Fri, 30 Sep 2011 10:30am
Janette Dixon, VP, Global Business Development
Dr John Holaday
QRX discusses recent milestones and rights issue
Wed, 10 Aug 2011 11:00am
John Holaday, Managing Director & CEO
Dr John Holaday
QRxPharma completes comparative safety study data - John Holaday, Managing Director & CEO
Wed, 15 Jun 2011 12:30pm
Dr John Holaday
QRxPharma Initiates Pivotal Phase 3 Study of MoxDuoIR - Dr John Holaday, Managing Director, CEO, Director
Mon, 7 Dec 2009 1:30pm
Icon_lastIcon_nextIcon_previousIcon_first